A nurse in a provider's office is assisting in the care of a client. The nurse is reviewing the client's electronic medical record. For each body system below, click to specify the finding that indicates the client is progressing as expected. Choose the most likely response for the dropdown(s) in the table below by choosing from the lists of options.

Endocrine Total thyroxine: The client’s total thyroxine increased from 4.5 mcg/dL to 5.2 mcg/dL, moving into the lower end of the normal range (5–12 mcg/dL). This indicates that levothyroxine therapy is effective and the client’s thyroid function is progressing toward expected levels. Monitoring total thyroxine provides a direct measure of thyroid hormone replacement efficacy. HbA1c: HbA1c remains elevated at 6.7% (normal 4–5.9%), indicating suboptimal glycemic control. While slightly improved from the previous value of 6.6%, it does not yet indicate expected progression. Fasting blood glucose: The client’s fasting glucose is 126 mg/dL (normal 70–110 mg/dL), which is still above target for clients with diabetes. This shows that glycemic control is not yet at the expected therapeutic level. Cardiovascular HDL level: The client’s HDL improved from 25 mg/dL to 50 mg/dL, exceeding the recommended minimum of 45 mg/dL. This indicates positive progression in cardiovascular risk reduction. HDL is a protective cholesterol fraction, and an increase suggests effective management of hyperlipidemia, likely due to lifestyle changes or lovastatin therapy. Heart rate: The client’s heart rate decreased slightly to 56–58 bpm, which is borderline bradycardic. This does not directly reflect cardiovascular improvement in the context of this case. Foot pressure injury: The pressure injury progressed from stage 2 to stage 3 over 4 weeks, indicating worsening rather than expected progression. This suggests poor wound healing and potential peripheral vascular compromise, not cardiovascular improvement. Gastrointestinal Bowel movements: The client reports 3 soft-formed stools per week, consistent with their baseline and improved compared to prior constipation. This indicates that gastrointestinal function is stabilizing. Regular bowel movements are a sign of progression, particularly in the context of previous anorexia and constipation. Abdominal assessment: The client reports right upper quadrant pain and decreased appetite, which indicates ongoing gastrointestinal issues. These findings do not reflect expected progression and may require further assessment. Liver enzymes: AST and ALT have increased slightly (AST 37 U/L, ALT 40 U/L) above the upper limit of normal, suggesting mild liver enzyme elevation. This does not indicate expected progression and may need monitoring or evaluation for hepatotoxicity.